New immunotherapy targets tumors
Stanford researchers have developed a synthetic, tumor-targeting molecule that promotes immune activation and tumor regression in laboratory mice after it’s injected into their bloodstreams.
COVID-19 nasal spray vaccine
A potential COVID-19 vaccine, delivered via a squirt up the nose, shows promise in mice.
Epidemiologist Jennifer Kelsey dies
Kelsey was known for her teaching skills, her expertise in musculoskeletal disorders and her love of golden retrievers.
Helping autistic job seekers
Psychiatrist Lawrence Fung expanded his autism research into developing a program that helps those on the spectrum find jobs.
New chair of anesthesiology
Bateman, a Harvard faculty member and prominent health care leader, brings his expertise as a researcher in maternal health and faculty development to Stanford.
Playing style linked to NBA knee injuries
Basketball players who weave through defense to shoot the basket face a higher risk of tears in the anterior cruciate ligament (ACL), but after repair return to the same level of play.
Bypass surgery vs. stenting
Among heart-disease patients in a study who received stents, the incidence of a major complication — death, heart attack, stroke or the need for a repeat procedure — was 10.6% after a year. Among bypass patients, the rate was 6.9%.
Experts: Public health system needs overhaul
In the third installment of “The Pandemic Puzzle: Lessons from COVID-19,” leaders and experts in government, academia, health care and business said the U.S. government must step up to build and coordinate a true, robust public health system.
COVID-19 vaccines for 5- to 11-year-olds
Answers to frequently asked questions as COVID-19 vaccinations roll out for children as young as 5.
$12 million for stem cell trial
Stanford researcher Maria Grazia Roncarolo has been awarded $12 million by the California Institute for Regenerative Medicine for a trial aimed at improving the outcomes of stem cell transplants in children and young adults with blood cancers.